Skip to content
  • Twitter

Global Press Release Centre

Press Releases from Around the Globe distributed to a Worldwide Audience via Web, Email & Social Media

  • Home
  • Russian Releases
  • RSS Feed
  • About

Airspan Introduces 5G Millimeter Wave RAN Infrastructure Utilizing the Qualcomm FSM100xx 5G Platform

meggit-training

New Enforce Tac Exhibitor Meggitt Training Systems to Exhibit Portable, Small-Arms Simulator

Norsk Titanium & SAE International Develop First Directed Energy Deposition Specifications for Additive Manufacturing Professionals Worldwide

Orange Polska Selects MATRIXX Digital Commerce to Transform Customer Engagement

Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe

Bartek Ingredients Announces Capacity Increases

Clinical Trials

Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe

Arvelle Therapeutics GmbH to provide SK Biopharmaceuticals an upfront payment of $100 million with future milestone potential of up to $430 million A new CNS-focused company, Arvelle received one of […]

February 14, 2019February 14, 2019 Mat Europe, Switzerland

First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry

Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies 17/09/2018 — FLAGSTAFF, Ariz. — (BUSINESS WIRE) W. L. Gore & Associates, […]

September 17, 2018 Mat Europe, Netherlands, North America, United States

BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders

Regulatory Approvals In-Process; New Record Date to be Set Shortly 17/09/2018 — ALAMEDA, Calif. — (BUSINESS WIRE) BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, […]

September 17, 2018 Mat North America, United States

CorFlow Completes USD 9.7M in Seed Funding

14/09/2018 — BAAR, Switzerland — (BUSINESS WIRE) CorFlow Therapeutics AG (www.corflow-therapeutics.ch) today announced that the company has completed the 2nd close of its Seed+ financing round. To date, and since the CorFlow […]

September 14, 2018 Mat Europe, North America, Switzerland, United States

Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)

Dicerna to receive up to $201 million in upfront and success-based development and commercialization milestones, excluding royalties, for an undisclosed target The collaboration will investigate a new therapeutic approach that […]

November 2, 2017 Mat Canada, Europe, Germany, North America, United States

Phase III Study using 22nd Century’s SPECTRUM® Research Cigarettes Demonstrates Immediate Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm

“Minimally or non-addictive Very Low Nicotine cigarettes are the ultimate harm reduction strategy” 06/10/2017 — CLARENCE, N.Y. — (BUSINESS WIRE) 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology […]

October 6, 2017October 8, 2017 Mat Asia Pacific, Europe, Japan, North America, United States

Bionext Launches Biosight: an Online Platform That Will Revolutionize Pharmaceutical Research

Helps companies accelerate the development of new medications by reducing the failure rate during the clinical phase 21/06/2017 — STRASBOURG, France — (BUSINESS WIRE) Bionext, a bioinformatics company, announces today […]

June 21, 2017 Mat Canada, Europe, France, North America

Latest clinical research confirms that IQOS reduces smoker exposure to select harmful chemicals as compared to cigarette smoke

Studies conducted to date clearly indicate that IQOS is likely to present less risk of harm compared to smoking 27/03/2017 — LAUSANNE, Switzerland — (BUSINESS WIRE) Philip Morris International Inc. […]

March 27, 2017 Mat Asia Pacific, Europe, Japan, Switzerland

LFB S.A. Announced Today the Acceptance by U.S. Food and Drug Administration of the Filed Biologic License Application for Coagulation Factor VIIa Recombinant, (eptacog beta activated)

06/01/2017 — LES ULIS, France — (BUSINESS WIRE) LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of Coagulation Factor VIIa (Recombinant) as a treatment for congenital […]

January 6, 2017 Mat Canada, North America

ABOUND Data Presented at the World Conference on Lung Cancer Further Explores Safety and Efficacy of ABRAXANE® for Challenging Patient Populations

Interim study findings further support safety, efficacy and tolerability in squamous and elderly patients with advanced NSCLC, consistent with results previously seen in the pivotal Phase III trial 06/12/2016 — […]

December 6, 2016 Mat Canada, Europe, North America, Switzerland, United States

Posts navigation

Older posts
Search Press Releases
Archives
RSS Feeds
  • Entries RSS
Regions
  • Afghanistan
  • Africa
  • Argentina
  • Asia Pacific
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Belgium
  • Bermuda
  • Bosnia and Herzegovina
  • Brazil
  • British Virgin Islands
  • Brunei
  • Bulgaria
  • Canada
  • Caribbean
  • Cayman Islands
  • Central America
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Europe
  • Finland
  • France
  • French Guiana
  • Georgia
  • Germany
  • Greece
  • Guinea
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Luxembourg
  • Malaysia
  • Malta
  • Mexico
  • Middle East
  • Moldova
  • Monaco
  • Montenegro
  • Nepal
  • Netherlands
  • New Zealand
  • Nigeria
  • North America
  • Norway
  • Other Regions
  • Pakistan
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Romania
  • Russia
  • Saudi Arabia
  • Senegal
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South America
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • Taiwan
  • Thailand
  • Turkey
  • Turkmenistan
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • Venezuela
  • Vietnam
  • Yemen